Dovato is a medicine for treating infection with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). It is used to treat adults and adolescents over 12 years old who weigh at least 40 kg. This medicine contains the active substances dolutegravir and lamivudine and is used to treat infections that are not resistant to medicines of the same class as dolutegravir or to lamivudine.
Therapeutic Indication
### Therapeutic indication Dovato is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg, with no known or suspected resistance to the integrase inhibitor class, or lamivudine.
Therapeutic Area (MeSH)
N/AATC Code
J05AR
ATC Item
治疗HIV感染的抗病毒药, 复方
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
N/AINN / Common Names
N/AEMA Name
Dovato
Medicine Name
Dovato
Aliases
N/ANo risk management plan link.
